Search results for "Infectious diseases"
Joint guidelines issued for drug-susceptible pulmonary tuberculosis
A 4-drug regimen of isoniazid, rifampin, pyrazinamide, and ethambutol, followed by a continuation phase of 4 months of isoniazid and rifampin, remains the preferred initial treatment.
https://immattersacp.org/weekly/archives/2016/08/16/5.htm
16 Aug 2016
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://immattersacp.org/weekly/archives/2017/08/08/2.htm
8 Aug 2017
Antibiotic stewardship improved prescribing for suspected UTI in frail older adults
Inappropriate antibiotic prescribing for suspected urinary tract infections (UTIs) was reduced in practices and facilities assigned to use a decision tool instead of usual care, particularly for patients with dementia, a randomized trial in Europe found.
https://immattersacp.org/weekly/archives/2023/02/28/5.htm
28 Feb 2023
Guidelines suggest fidaxomicin over vancomycin for Clostridioides difficile infection
The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America made three new recommendations in a focused update of their guidelines on Clostridioides difficile infection.
https://immattersacp.org/weekly/archives/2021/06/29/5.htm
29 Jun 2021
Obituaries
The College notes the passing of Michael F. Rein, MD, MACP; William R. Smith, MD, MACP; Cyril (Kim) M. Hetsko, MD, MACP; and Alan Gordon, MD, MACP.
https://immattersacp.org/archives/2023/01/obituaries.htm
1 Jan 2023
Internal Medicine Meeting 2021: Virtual Experience to feature three plenary speakers, including Dr. Anthony Fauci
Join ACP for internal medicine's most comprehensive educational program in a new, engaging, interactive, and virtual format.
https://immattersacp.org/weekly/archives/2021/02/23/6.htm
23 Feb 2021
Prepare for next pandemic by training leaders
In response to the COVID-19 pandemic and the prospect of others, public health and medical groups are developing training initiatives to increase the numbers of infectious disease and public health specialists across the country.
https://immattersacp.org/archives/2023/03/prepare-for-next-pandemic-by-training-leaders.htm
1 Mar 2023
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
DEI or DIE?
The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021